Editorial Commentary: Considerations of Favipiravir as a Medical Countermeasure in Future Randomized Controlled Trials Against Ebola Virus Disease

Clin Infect Dis. 2016 Nov 15;63(10):1295-1296. doi: 10.1093/cid/ciw575. Epub 2016 Aug 23.
No abstract available

Keywords: Ebola virus disease; Sierra Leone; clinical trials; favipiravir; treatment.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Amides
  • Disease Outbreaks
  • Ebolavirus
  • Hemorrhagic Fever, Ebola*
  • Humans
  • Pyrazines
  • Randomized Controlled Trials as Topic*
  • Sierra Leone

Substances

  • Amides
  • Pyrazines
  • favipiravir